Literature DB >> 11858777

Cardiovascular Complications of Collagen Vascular Disease.

Gary E. Sander1, Thomas D. Giles.   

Abstract

Collagen vascular diseases commonly affect the heart; cardiovascular events are the major cause of mortality in people with these diseases. A striking feature of the cardiac involvement in individuals with systemic lupus erythematosus (SLE) and rheumatoid arthritis is aggressive and accelerated atherosclerosis; women with SLE in the 35- to 44-year-old age group are more than 50 times more likely to suffer myocardial infarction than are matched controls. Traditional risk factors contribute to the accelerated atherosclerosis, but cannot explain the extent of risk. It is possible that the inflammatory process, which is similar to the inflammatory process in atherosclerosis, pays a critical pathophysiologic role. It is critically important to identify the presence of traditional cardiovascular risk factors (eg, tobacco usage, hypertension, hypercholesterolemia, diabetes, homocysteinemia), and to modify these to secondary prevention targets. Cardiac valvular disease is common in individuals with SLE and rheumatoid arthritis; its presence should be anticipated and subacute bacterial endocarditis prophylaxis precautions initiated. Cardiac autonomic neuropathy and conduction disturbances are common in people with heart disease related to systemic sclerosis and human leukocyte antigen B27; these patients should be monitored carefully for evidence of dysrhythmias.

Entities:  

Year:  2002        PMID: 11858777     DOI: 10.1007/s11936-002-0035-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  74 in total

1.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

2.  Macrovascular disease and systemic sclerosis.

Authors:  M Ho; D Veale; C Eastmond; G Nuki; J Belch
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

3.  Pathology of ankylosing spondylitis.

Authors: 
Journal:  Clin Orthop Relat Res       Date:  1971-01       Impact factor: 4.176

4.  Ultrasonic videodensitometric analysis in scleroderma heart disease.

Authors:  V Di Bello; C Ferri; D Giorgi; M Bianchi; A Bertini; A Martini; F A Storino; M Paterni; G Pasero; C Giusti
Journal:  Coron Artery Dis       Date:  1999       Impact factor: 1.439

5.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

6.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

7.  Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus.

Authors:  W H Leung; K L Wong; C P Lau; C K Wong; C H Cheng; Y T Tai
Journal:  Am Heart J       Date:  1990-07       Impact factor: 4.749

8.  Cardiac involvement in systemic lupus erythematosus detected by echocardiography.

Authors:  I G Crozier; E Li; M J Milne; M G Nicholls
Journal:  Am J Cardiol       Date:  1990-05-01       Impact factor: 2.778

9.  The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study.

Authors:  D A Brewerton; D G Gibson; D H Goddard; T J Jones; R B Moore; C T Pease; P A Revell; L M Shapiro; K V Swettenham
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

10.  Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease.

Authors:  S Corrao; L Sallì; S Arnone; R Scaglione; A Pinto; G Licata
Journal:  Eur J Clin Invest       Date:  1996-04       Impact factor: 4.686

View more
  1 in total

Review 1.  Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Authors:  Natalia Milioti; Alexandra Bermudez-Fajardo; Manuel L Penichet; Ernesto Oviedo-Orta
Journal:  Clin Dev Immunol       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.